BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20421811)

  • 1. Serum B12 concentration is elevated in patients receiving chronic parenteral nutrition, but is not a marker of intestinal failure-associated liver disease.
    Elkhatib I; Cao W; Rao S; Fryer J; Buchman AL
    J Clin Gastroenterol; 2010 Sep; 44(8):571-4. PubMed ID: 20421811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition.
    Putchakayala K; Polensky S; Fitzhugh J; Cohran V; Buchman A; Fryer J
    JPEN J Parenter Enteral Nutr; 2009; 33(1):55-61. PubMed ID: 18941030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction?
    Nasr A; Diamond IR; de Silva NT; Wales PW
    J Pediatr Surg; 2010 May; 45(5):980-6. PubMed ID: 20438939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation.
    Lacaille F; Vass N; Sauvat F; Canioni D; Colomb V; Talbotec C; De Serre NP; Salomon J; Hugot JP; Cézard JP; Révillon Y; Ruemmele FM; Goulet O
    Gut; 2008 Apr; 57(4):455-61. PubMed ID: 18079282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral nutrition associated liver disease.
    Kaufman SS; Gondolesi GE; Fishbein TM
    Semin Neonatol; 2003 Oct; 8(5):375-81. PubMed ID: 15001125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of longitudinal intestinal lengthening and tailoring on liver function in short bowel syndrome.
    Reinshagen K; Zahn K; Buch Cv; Zoeller M; Hagl CI; Ali M; Waag KL
    Eur J Pediatr Surg; 2008 Aug; 18(4):249-53. PubMed ID: 18704888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic ultrastructure in a neonatal piglet model of intestinal failure-associated liver disease (IFALD).
    Hua Z; Sergi C; Nation PN; Wizzard PR; Ball RO; Pencharz PB; Turner JM; Wales PW
    J Electron Microsc (Tokyo); 2012 Jun; 61(3):179-86. PubMed ID: 22366032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short bowel syndrome and intestinal transplantation in children.
    Goulet O; Sauvat F
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):304-13. PubMed ID: 16607133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal failure-associated liver disease: what do we know today?
    Kelly DA
    Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Crohn's disease in patients with intestinal failure: a role for bacteria?
    Walzer N; Buchman AL
    J Clin Gastroenterol; 2010; 44(5):361-3. PubMed ID: 20054284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring holotranscobalamin II, an early indicator of negative vitamin B12 balance, by radioimmunoassay in patients with ischemic cerebrovascular disease.
    Serefhanoglu S; Aydogdu I; Kekilli E; Ilhan A; Kuku I
    Ann Hematol; 2008 May; 87(5):391-5. PubMed ID: 17992530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
    Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
    Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of enteral nutrition in adult short bowel syndrome undergoing intestinal rehabilitation: the long-term outcome.
    Gong JF; Zhu WM; Yu WK; Li N; Li JS
    Asia Pac J Clin Nutr; 2009; 18(2):155-63. PubMed ID: 19713173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics.
    Chungfat N; Dixler I; Cohran V; Buchman A; Abecassis M; Fryer J
    J Am Coll Surg; 2007 Dec; 205(6):755-61. PubMed ID: 18035258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure.
    Mutanen A; Lohi J; Heikkilä P; Jalanko H; Pakarinen MP
    J Hepatol; 2015 Jun; 62(6):1391-7. PubMed ID: 25595885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver disease associated with long-term parenteral nutrition in children.
    Colomb V; Goulet O; De Potter S; Ricour C
    Transplant Proc; 1994 Jun; 26(3):1467. PubMed ID: 8029991
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term outcomes of short bowel syndrome requiring long-term/home intravenous nutrition compared in children with gastroschisis and those with volvulus.
    Sala D; Chomto S; Hill S
    Transplant Proc; 2010; 42(1):5-8. PubMed ID: 20172269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated liver transplantation in pediatric short bowel syndrome: is there a role?
    Diamond IR; Wales PW; Grant DR; Fecteau A
    J Pediatr Surg; 2006 May; 41(5):955-9. PubMed ID: 16677892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.